Brigham and Women’s Hospital (BWH) stage T2a squamous cell carcinoma (SCC), demonstrating a single high-risk feature, have a low risk for metastasis and death but an increased risk of local recurrence. Little evidence exists for the best treatment modality and…

Only a minority of people with venous insufficiency develop ulceration. Understanding the first ulceration event may help to understand this discrepancy and guide management. Being male, older and receiving anticoagulant or anti-hypertensive therapy are risk factors for ulcerations. Protective factors…

Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with baseline serum levels of IgE and TARC but not subjective severity scores in a real-world setting. These objective parameters are useful as practical predictors of later development of…

Network meta-analyses on biologic treatment efficacy at a single time point have been reported. This article reports the cumulative efficacy over time for different biologic treatments. Knowledge on the cumulative benefits of treatments, which combines the rapidity and magnitude of…

The Hidradenitis Suppurativa Clinical Response (HiSCR) is the gold standard primary outcome measure for Hidradenitis Suppurativa (HS) clinical trials, however it does not assess the presence of draining tunnels, a common finding in advanced disease. It is unclear what the…